Gemcitabine and cancer of the pancreas: new preparation. Helpful or not?
(1) The clinical file of gemcitabine in locally advanced metastatic adenocarcinoma of the pancreas mainly comprises one comparative trial versus 5 fluorouracil that shows the superiority of gemcitabine on a mixed end point (pain, functional capacities, weight). (2) In this trial haematotoxicity (anaemia and neutropenia) and nausea and vomiting were more common on gemcitabine.